Azerizin is claimed to be a proprietary blend of the natural ingredients nicotinamide, azelaic acid, quercetin and curcumin that purportedly combine the anti-inflammatory and antimicrobial properties, along with inhibiting effects on sebum production.
In addition to these anti-inflammatory actions, the components of Azerizin possess potent antimicrobial activity against Propionibacterium acnes and Staphylococcus epidermis, at least in part attributed to inhibition of microbial cellular protein synthesis. Azerizin was developed by scientists at Elorac, Inc. for use as an adjunct in the management of acne vulgaris and rosacea.
^Chirumbolo, S (Sep 2010). "The role of quercetin, flavonols and flavones in modulating inflammatory cell function". Inflamm Allergy Drug Targets9 (4): 263–85. doi:10.2174/187152810793358741.
^Fivenson, DP (Jan 2006). "The mechanisms of action of nicotinamide and zinc in inflammatory skin disease". Cutis ((1 Suppl)): 5–10.
^Jurenka, Julie S (2 Nov 2009). "Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research". Alternative Medicine Review14 (f2): 141–153.
^Shalita, A; Falcon R; Olansky A; Oannotta P; Akhavan A; Day D; Janiga A; Singri P et al. (2012). "Inflammatory acne management with a novel prescription dietary supplement". J of Drugs in Derm11.|displayauthors= suggested (help)
^Liu, C; Huang H (2013). "In Vitro Anti-Propionibacterium Activity by Curcumin Containing Vesicle System". Chem Pharm Bull61 (4): 419–425. doi:10.1248/cpb.c12-01043.
^Fitton, Andrew; Goa, Karen L (1991). "Azelaic acid: A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders". Drugs41 (5): 780–798. doi:10.2165/00003495-199141050-00007.